Regeneron Pharmaceuticals, Inc. (REGN)

771.90 -2.04 (-0.26%) USD  |  NASDAQ  |  Dec 31, 16:00
773.60 +1.70 (+0.22%) After-Hours: 20:00
More

Regeneron Pharmaceuticals Total Operating Expenses (Quarterly)

Total Operating Expenses (Quarterly) Chart

View Total Operating Expenses (Quarterly) for REGN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Operating Expenses (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Operating Expenses (Quarterly) Range, Past 5 Years

View Total Operating Expenses (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Operating Expenses (Quarterly) Benchmarks

View Total Operating Expenses (Quarterly) Benchmarks
Start Trial
Amgen, Inc. Upgrade
Gilead Sciences, Inc. Upgrade
Johnson & Johnson Upgrade
Eli Lilly & Co. Upgrade
Merck & Co., Inc. Upgrade